_MEMBER_MyList,_LogP_MyList,GO,_PATTERN_,_RANK_,GiniIndex,Category,CategoryID,Description,PARENT_GO,LogP,Enrichment,Z-score,#TotalGeneInLibrary,#GeneInGO,#GeneInHitList,#GeneInGOAndHitList,%InGO,STDV %InGO,GeneID,Hits,Log(q-value),EvidenceCutoff
1,-6.8,C0410702,M1,1,0,DisGeNET,35,Adolescent idiopathic scoliosis,,-6.8,10,8.8,30304,656,40,9,22,6.6,3479|5649|9242|9586|9760|55553|65217|221395|100132891,IGF1|RELN|MSC|CREB5|TOX|SOX6|PCDH15|ADGRF5|MSC-AS1,-3.1,0
1,-5.8,C4551463,M1,1,0,DisGeNET,35,Colon adenoma,,-5.8,48,14,30304,63,40,4,10,4.7,2122|3479|6256|23213,MECOM|IGF1|RXRA|SULF1,-2.6,0
1,-5.2,C2347613,M1,1,0,DisGeNET,35,Childhood Atypical Teratoid/Rhabdoid Tumor,,-5.2,81,15,30304,28,40,3,7.5,4.2,2146|3479|63976,EZH2|IGF1|PRDM16,-2.1,0
1,-5,C1837461,M1,1,0,DisGeNET,35,"SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3",,-5,9.2,7.2,30304,578,40,7,18,6,5649|9586|9760|55553|65217|221395|100132891,RELN|CREB5|TOX|SOX6|PCDH15|ADGRF5|MSC-AS1,-2,0
1,-4.7,C1961099,M1,1,0,DisGeNET,35,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,,-4.7,8.2,6.7,30304,644,40,7,18,6,2078|2122|2146|3479|9760|22806|63976,ERG|MECOM|EZH2|IGF1|TOX|IKZF3|PRDM16,-1.8,0
1,-4.5,C1739405,M1,1,0,DisGeNET,35,CML progression,,-4.5,48,12,30304,47,40,3,7.5,4.2,2122|2146|3479,MECOM|EZH2|IGF1,-1.7,0
1,-4.4,C0038013,M1,1,0,DisGeNET,35,Ankylosing spondylitis,,-4.4,7.5,6.3,30304,710,40,7,18,6,639|864|2078|2122|3479|9242|84959,PRDM1|RUNX3|ERG|MECOM|IGF1|MSC|UBASH3B,-1.7,0
1,-4.4,C1879321,M1,1,0,DisGeNET,35,Acute Myeloid Leukemia (AML-M2),,-4.4,21,8.8,30304,143,40,4,10,4.7,864|2078|2122|4603,RUNX3|ERG|MECOM|MYBL1,-1.7,0
1,-4.4,C1275278,M1,1,0,DisGeNET,35,Extraskeletal Myxoid Chondrosarcoma,,-4.4,45,11,30304,50,40,3,7.5,4.2,4603|6938|55553,MYBL1|TCF12|SOX6,-1.7,0
1,-4.4,C0036220,M1,1,0,DisGeNET,35,Kaposi Sarcoma,,-4.4,9.3,6.7,30304,488,40,6,15,5.6,864|2078|2146|3479|9242|84959,RUNX3|ERG|EZH2|IGF1|MSC|UBASH3B,-1.7,0
1,-4.3,C0428883,M1,1,0,DisGeNET,35,Diastolic blood pressure,,-4.3,9,6.6,30304,507,40,6,15,5.6,2078|2122|10365|55553|57194|63976,ERG|MECOM|KLF2|SOX6|ATP10A|PRDM16,-1.6,0
1,-4.3,C0553580,M1,1,0,DisGeNET,35,Ewings sarcoma,,-4.3,8.8,6.5,30304,517,40,6,15,5.6,864|2078|2146|3479|5649|285987,RUNX3|ERG|EZH2|IGF1|RELN|DLX6-AS1,-1.6,0
1,-4.2,C0000846,M1,1,0,DisGeNET,35,Agenesis,,-4.2,19,8.2,30304,161,40,4,10,4.7,864|2122|2138|9242,RUNX3|MECOM|EYA1|MSC,-1.5,0
1,-4.2,C0280280,M1,1,0,DisGeNET,35,"stage, prostate cancer",,-4.2,39,11,30304,58,40,3,7.5,4.2,2078|2146|3479,ERG|EZH2|IGF1,-1.5,0
1,-4.2,C0220620,M1,1,0,DisGeNET,35,Gastrointestinal Carcinoid Tumor,,-4.2,12,7,30304,323,40,5,12,5.2,639|864|2078|2146|3479,PRDM1|RUNX3|ERG|EZH2|IGF1,-1.5,0
1,-4.1,C0263630,M1,1,0,DisGeNET,35,"Hypertrophic disorder of skin, unspecified",,-4.1,37,10,30304,62,40,3,7.5,4.2,2146|3479|84959,EZH2|IGF1|UBASH3B,-1.5,0
1,-4.1,C0029458,M1,1,0,DisGeNET,35,"Osteoporosis, Postmenopausal",,-4.1,18,8,30304,171,40,4,10,4.7,2146|3479|6660|221395,EZH2|IGF1|SOX5|ADGRF5,-1.5,0
1,-4.1,C2945695,M1,1,0,DisGeNET,35,Limb ischemia,,-4.1,18,8,30304,171,40,4,10,4.7,2146|3479|9242|10365,EZH2|IGF1|MSC|KLF2,-1.5,0
1,-4,C0265219,M1,1,0,DisGeNET,35,Miller Dieker syndrome,,-4,17,7.7,30304,182,40,4,10,4.7,2122|2146|9242|63976,MECOM|EZH2|MSC|PRDM16,-1.4,0
1,-4,C3469521,M1,1,0,DisGeNET,35,"FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)",,-4,11,6.6,30304,359,40,5,12,5.2,864|2122|2146|3479|9242,RUNX3|MECOM|EZH2|IGF1|MSC,-1.3,0
1,-3.9,C1292778,M1,1,0,DisGeNET,35,Chronic myeloproliferative disorder,,-3.9,10,6.5,30304,366,40,5,12,5.2,864|2122|2146|3479|9242,RUNX3|MECOM|EZH2|IGF1|MSC,-1.3,0
1,-3.9,C0038273,M1,1,0,DisGeNET,35,Stereotypic Movement Disorder,,-3.9,16,7.5,30304,192,40,4,10,4.7,2571|5649|6660|63976,GAD1|RELN|SOX5|PRDM16,-1.3,0
1,-3.9,C1527349,M1,1,0,DisGeNET,35,Ductal Breast Carcinoma,,-3.9,15,7.4,30304,196,40,4,10,4.7,864|2078|2146|170691,RUNX3|ERG|EZH2|ADAMTS17,-1.3,0
1,-3.8,C0023470,M1,1,0,DisGeNET,35,Myeloid Leukemia,,-3.8,9.8,6.3,30304,385,40,5,12,5.2,2078|2122|2146|3479|63976,ERG|MECOM|EZH2|IGF1|PRDM16,-1.3,0
1,-3.8,C0040420,M1,1,0,DisGeNET,35,Tonometry,,-3.8,15,7.2,30304,206,40,4,10,4.7,2122|5649|51705|170691,MECOM|RELN|EMCN|ADAMTS17,-1.2,0
1,-3.8,C0015625,M1,1,0,DisGeNET,35,Fanconi Anemia,,-3.8,9.6,6.3,30304,393,40,5,12,5.2,864|2122|2146|3479|9242,RUNX3|MECOM|EZH2|IGF1|MSC,-1.2,0
1,-3.8,C1739135,M1,1,0,DisGeNET,35,Progression of prostate cancer,,-3.8,9.5,6.2,30304,398,40,5,12,5.2,1745|2078|2146|3479|6660,DLX1|ERG|EZH2|IGF1|SOX5,-1.2,0
1,-3.7,C0220621,M1,1,0,DisGeNET,35,Childhood Acute Myeloid Leukemia,,-3.7,14,7,30304,215,40,4,10,4.7,864|2078|2122|63976,RUNX3|ERG|MECOM|PRDM16,-1.2,0
1,-3.7,C1266184,M1,1,0,DisGeNET,35,Atypical Teratoid Rhabdoid Tumor,,-3.7,27,8.7,30304,84,40,3,7.5,4.2,2146|3479|63976,EZH2|IGF1|PRDM16,-1.2,0
1,-3.7,C0399440,M1,1,0,DisGeNET,35,Hereditary gingival fibromatosis,,-3.7,26,8.6,30304,86,40,3,7.5,4.2,2146|3479|9242,EZH2|IGF1|MSC,-1.2,0
1,-3.6,C0006287,M1,1,0,DisGeNET,35,Bronchopulmonary Dysplasia,,-3.6,9,6,30304,423,40,5,12,5.2,2146|2571|3479|5649|9242,EZH2|GAD1|IGF1|RELN|MSC,-1.1,0
1,-3.6,C0023508,M1,1,0,DisGeNET,35,White Blood Cell Count procedure,,-3.6,6.7,5.4,30304,681,40,6,15,5.6,864|2078|9586|22806|55553|221395,RUNX3|ERG|CREB5|IKZF3|SOX6|ADGRF5,-1.1,0
1,-3.6,C0398791,M1,1,0,DisGeNET,35,Nijmegen Breakage Syndrome,,-3.6,24,8.2,30304,94,40,3,7.5,4.2,2078|3479|84959,ERG|IGF1|UBASH3B,-1.1,0
1,-3.6,C0432072,M1,1,0,DisGeNET,35,Dysmorphic features,,-3.6,8.6,5.9,30304,439,40,5,12,5.2,2146|3479|5649|6660|55553,EZH2|IGF1|RELN|SOX5|SOX6,-1.1,0
1,-3.5,C0039585,M1,1,0,DisGeNET,35,Androgen-Insensitivity Syndrome,,-3.5,12,6.5,30304,247,40,4,10,4.7,2571|3479|9242|55553,GAD1|IGF1|MSC|SOX6,-1.1,0
1,-3.5,C0432283,M1,1,0,DisGeNET,35,Osteoglophonic dwarfism,,-3.5,23,7.9,30304,100,40,3,7.5,4.2,2146|9242|10365,EZH2|MSC|KLF2,-1.1,0
1,-3.5,C0038379,M1,1,0,DisGeNET,35,Strabismus,,-3.5,6.3,5.3,30304,716,40,6,15,5.6,2078|2146|6660|6913|6938|63976,ERG|EZH2|SOX5|TBX15|TCF12|PRDM16,-1.1,0
1,-3.5,C0014772,M1,1,0,DisGeNET,35,Red Blood Cell Count measurement,,-3.5,6.3,5.3,30304,717,40,6,15,5.6,2078|2122|8537|55553|63976|84959,ERG|MECOM|BCAS1|SOX6|PRDM16|UBASH3B,-1.1,0
1,-3.5,C3642346,M1,1,0,DisGeNET,35,Luminal B Breast Carcinoma,,-3.5,22,7.8,30304,103,40,3,7.5,4.2,2138|2146|22806,EYA1|EZH2|IKZF3,-1,0
1,-3.4,C1834582,M1,1,0,DisGeNET,35,"MYELOPROLIFERATIVE SYNDROME, TRANSIENT",,-3.4,22,7.7,30304,105,40,3,7.5,4.2,2078|2146|3479,ERG|EZH2|IGF1,-1,0
1,-3.4,C0032927,M1,1,0,DisGeNET,35,Precancerous Conditions,,-3.4,8,5.6,30304,471,40,5,12,5.2,864|2122|2146|3479|23213,RUNX3|MECOM|EZH2|IGF1|SULF1,-1,0
1,-3.4,C0024301,M1,1,0,DisGeNET,35,"Lymphoma, Follicular",,-3.4,7.9,5.6,30304,477,40,5,12,5.2,639|2146|6660|9242|10365,PRDM1|EZH2|SOX5|MSC|KLF2,-1,0
1,-3.4,C1306710,M1,1,0,DisGeNET,35,Facial asymmetry,,-3.4,21,7.5,30304,109,40,3,7.5,4.2,2138|6660|6938,EYA1|SOX5|TCF12,-1,0
1,-3.4,C0079772,M1,1,0,DisGeNET,35,T-Cell Lymphoma,,-3.4,7.8,5.5,30304,485,40,5,12,5.2,639|864|2146|3479|51705,PRDM1|RUNX3|EZH2|IGF1|EMCN,-1,0
1,-3.3,C0027092,M1,1,0,DisGeNET,35,Myopia,,-3.3,7.7,5.5,30304,490,40,5,12,5.2,2078|2571|3479|6660|170691,ERG|GAD1|IGF1|SOX5|ADAMTS17,-1,0
1,-3.3,C0206638,M1,1,0,DisGeNET,35,Giant Cell Tumor of Bone,,-3.3,20,7.4,30304,113,40,3,7.5,4.2,864|3479|9242,RUNX3|IGF1|MSC,-1,0
1,-3.3,C2931456,M1,1,0,DisGeNET,35,"Prostate cancer, familial",,-3.3,20,7.3,30304,116,40,3,7.5,4.2,2078|2122|8537,ERG|MECOM|BCAS1,-0.99,0
1,-3.3,C0684337,M1,1,0,DisGeNET,35,Ewings sarcoma-primitive neuroectodermal tumor (PNET),,-3.3,19,7.3,30304,117,40,3,7.5,4.2,2078|2146|3479,ERG|EZH2|IGF1,-0.99,0
1,-3.3,C0151779,M1,1,0,DisGeNET,35,Cutaneous Melanoma,,-3.3,7.5,5.3,30304,507,40,5,12,5.2,864|2146|3479|6256|63976,RUNX3|EZH2|IGF1|RXRA|PRDM16,-0.98,0
1,-3.3,C0280141,M1,1,0,DisGeNET,35,Acute Undifferentiated Leukemia,,-3.3,19,7.2,30304,119,40,3,7.5,4.2,2078|2146|3479,ERG|EZH2|IGF1,-0.98,0
1,-3.3,C1850049,M1,1,0,DisGeNET,35,Clinodactyly of the 5th finger,,-3.3,11,6,30304,284,40,4,10,4.7,2122|3479|6913|63976,MECOM|IGF1|TBX15|PRDM16,-0.98,0
1,-3.3,C0018784,M1,1,0,DisGeNET,35,Sensorineural Hearing Loss (disorder),,-3.3,5.8,5,30304,783,40,6,15,5.6,2122|2138|3479|9242|63976|65217,MECOM|EYA1|IGF1|MSC|PRDM16|PCDH15,-0.98,0
1,-3.3,C1333064,M1,1,0,DisGeNET,35,Classical Hodgkin's Lymphoma,,-3.3,11,5.9,30304,285,40,4,10,4.7,639|2146|3479|9242,PRDM1|EZH2|IGF1|MSC,-0.98,0
1,-3.3,C0221369,M1,1,0,DisGeNET,35,Acquired Camptodactyly,,-3.3,19,7.2,30304,120,40,3,7.5,4.2,2146|3479|6913,EZH2|IGF1|TBX15,-0.98,0
1,-3.3,C1378511,M1,1,0,DisGeNET,35,Undifferentiated leukemia,,-3.3,19,7.2,30304,120,40,3,7.5,4.2,2122|2146|3479,MECOM|EZH2|IGF1,-0.98,0
1,-3.3,C0023448,M1,1,0,DisGeNET,35,Lymphoid leukemia,,-3.3,11,5.9,30304,288,40,4,10,4.7,2078|2122|2146|3479,ERG|MECOM|EZH2|IGF1,-0.97,0
1,-3.2,C0685409,M1,1,0,DisGeNET,35,Congenital Camptodactyly,,-3.2,18,7.1,30304,123,40,3,7.5,4.2,2146|3479|6913,EZH2|IGF1|TBX15,-0.96,0
1,-3.2,C0018498,M1,1,0,DisGeNET,35,Hair Color,,-3.2,17,6.8,30304,130,40,3,7.5,4.2,8537|9586|55553,BCAS1|CREB5|SOX6,-0.9,0
1,-3.2,C0020507,M1,1,0,DisGeNET,35,Hyperplasia,,-3.2,17,6.8,30304,131,40,3,7.5,4.2,2146|3479|6256,EZH2|IGF1|RXRA,-0.89,0
1,-3.1,C0007766,M1,1,0,DisGeNET,35,Intracranial Aneurysm,,-3.1,9.7,5.6,30304,311,40,4,10,4.7,3479|6938|9760|10365,IGF1|TCF12|TOX|KLF2,-0.86,0
1,-3.1,C0005940,M1,1,0,DisGeNET,35,Bone Diseases,,-3.1,9.6,5.6,30304,317,40,4,10,4.7,3479|9242|10365|63976,IGF1|MSC|KLF2|PRDM16,-0.84,0
1,-3.1,C0026998,M1,1,0,DisGeNET,35,"Acute Myeloid Leukemia, M1",,-3.1,16,6.6,30304,138,40,3,7.5,4.2,864|2078|2122,RUNX3|ERG|MECOM,-0.84,0
1,-3.1,C0221354,M1,1,0,DisGeNET,35,Frontal bossing,,-3.1,9.4,5.5,30304,321,40,4,10,4.7,6660|6913|6938|63976,SOX5|TBX15|TCF12|PRDM16,-0.82,0
1,-3.1,C4721208,M1,1,0,DisGeNET,35,Metastatic castration-resistant prostate cancer,,-3.1,16,6.6,30304,140,40,3,7.5,4.2,2078|2146|6660,ERG|EZH2|SOX5,-0.82,0
1,-3.1,C0221357,M1,1,0,DisGeNET,35,Brachydactyly,,-3.1,9.3,5.5,30304,325,40,4,10,4.7,6913|6938|63976|170691,TBX15|TCF12|PRDM16|ADAMTS17,-0.81,0
1,-3,C0238301,M1,1,0,DisGeNET,35,Cancer of Nasopharynx,,-3,16,6.4,30304,145,40,3,7.5,4.2,2122|2146|3479,MECOM|EZH2|IGF1,-0.79,0
1,-3,C0279680,M1,1,0,DisGeNET,35,Transitional cell carcinoma of bladder,,-3,9.1,5.4,30304,333,40,4,10,4.7,2146|3479|6256|23213,EZH2|IGF1|RXRA|SULF1,-0.78,0
1,-3,C4551649,M1,1,0,DisGeNET,35,Congenital Dysplasia Of The Hip,,-3,15,6.4,30304,147,40,3,7.5,4.2,2138|3479|6913,EYA1|IGF1|TBX15,-0.78,0
1,-3,C0424605,M1,1,0,DisGeNET,35,Developmental delay (disorder),,-3,6.5,4.9,30304,584,40,5,12,5.2,2138|3479|6660|6938|65217,EYA1|IGF1|SOX5|TCF12|PCDH15,-0.78,0
1,-3,C0013363,M1,1,0,DisGeNET,35,Dysautonomia,,-3,15,6.4,30304,148,40,3,7.5,4.2,2571|3479|10365,GAD1|IGF1|KLF2,-0.78,0
1,-3,C4551485,M1,1,0,DisGeNET,35,Clinodactyly,,-3,15,6.4,30304,148,40,3,7.5,4.2,2146|3479|6660,EZH2|IGF1|SOX5,-0.78,0
1,-3,C0007112,M1,1,0,DisGeNET,35,Adenocarcinoma of prostate,,-3,8.9,5.3,30304,342,40,4,10,4.7,2078|2571|3479|6256,ERG|GAD1|IGF1|RXRA,-0.75,0
1,-2.9,C0751956,M1,1,0,DisGeNET,35,Acute Cerebrovascular Accidents,,-2.9,15,6.2,30304,155,40,3,7.5,4.2,3479|6256|10365,IGF1|RXRA|KLF2,-0.73,0
1,-2.9,C0949690,M1,1,0,DisGeNET,35,Spondylarthritis,,-2.9,14,6.1,30304,158,40,3,7.5,4.2,864|3479|9242,RUNX3|IGF1|MSC,-0.71,0
1,-2.9,C0023051,M1,1,0,DisGeNET,35,Laryngeal Diseases,,-2.9,14,6.1,30304,159,40,3,7.5,4.2,2146|3479|9242,EZH2|IGF1|MSC,-0.71,0
1,-2.9,C4733092,M1,1,0,DisGeNET,35,estrogen receptor-negative breast cancer,,-2.9,8.5,5.2,30304,356,40,4,10,4.7,2122|2146|3479|84959,MECOM|EZH2|IGF1|UBASH3B,-0.71,0
1,-2.9,C0162770,M1,1,0,DisGeNET,35,Right Ventricular Hypertrophy,,-2.9,14,6.1,30304,160,40,3,7.5,4.2,2146|3479|5649,EZH2|IGF1|RELN,-0.71,0
1,-2.9,C0220615,M1,1,0,DisGeNET,35,Adult Acute Myeloblastic Leukemia,,-2.9,14,6.1,30304,160,40,3,7.5,4.2,2078|2122|63976,ERG|MECOM|PRDM16,-0.71,0
1,-2.9,C0265610,M1,1,0,DisGeNET,35,Clinodactyly of fingers,,-2.9,14,6.1,30304,160,40,3,7.5,4.2,2146|3479|6660,EZH2|IGF1|SOX5,-0.71,0
1,-2.9,C0175754,M1,1,0,DisGeNET,35,Agenesis of corpus callosum,,-2.9,6.2,4.7,30304,615,40,5,12,5.2,864|2146|3479|4603|63976,RUNX3|EZH2|IGF1|MYBL1|PRDM16,-0.71,0
1,-2.9,C0041956,M1,1,0,DisGeNET,35,Ureteral obstruction,,-2.9,8.4,5.2,30304,359,40,4,10,4.7,2146|3479|9242|51705,EZH2|IGF1|MSC|EMCN,-0.7,0
1,-2.9,C0018923,M1,1,0,DisGeNET,35,Hemangiosarcoma,,-2.9,14,6,30304,162,40,3,7.5,4.2,2078|51705|84959,ERG|EMCN|UBASH3B,-0.7,0
1,-2.9,C0162298,M1,1,0,DisGeNET,35,Joint stiffness,,-2.9,14,6,30304,163,40,3,7.5,4.2,2146|63976|170691,EZH2|PRDM16|ADAMTS17,-0.7,0
1,-2.9,C0346429,M1,1,0,DisGeNET,35,Multiple malignancy,,-2.9,14,6,30304,163,40,3,7.5,4.2,2078|2146|3479,ERG|EZH2|IGF1,-0.7,0
1,-2.9,C0027022,M1,1,0,DisGeNET,35,Myeloproliferative disease,,-2.9,8.3,5.1,30304,365,40,4,10,4.7,864|2122|2146|55553,RUNX3|MECOM|EZH2|SOX6,-0.69,0
1,-2.9,C0338831,M1,1,0,DisGeNET,35,Manic,,-2.9,14,6,30304,166,40,3,7.5,4.2,2571|3479|5649,GAD1|IGF1|RELN,-0.68,0
1,-2.9,C0023465,M1,1,0,DisGeNET,35,Acute monocytic leukemia,,-2.9,6,4.6,30304,633,40,5,12,5.2,2078|2122|2146|55553|63976,ERG|MECOM|EZH2|SOX6|PRDM16,-0.67,0
1,-2.8,C0086692,M1,1,0,DisGeNET,35,Benign Neoplasm,,-2.8,8.2,5.1,30304,371,40,4,10,4.7,2078|2122|2146|3479,ERG|MECOM|EZH2|IGF1,-0.67,0
1,-2.8,C1292753,M1,1,0,DisGeNET,35,Primary Effusion Lymphoma,,-2.8,13,5.9,30304,169,40,3,7.5,4.2,639|9242|22806,PRDM1|MSC|IKZF3,-0.67,0
1,-2.8,C0032000,M1,1,0,DisGeNET,35,Pituitary Adenoma,,-2.8,13,5.9,30304,170,40,3,7.5,4.2,2146|3479|65217,EZH2|IGF1|PCDH15,-0.66,0
1,-2.8,C0039538,M1,1,0,DisGeNET,35,Teratoma,,-2.8,13,5.9,30304,171,40,3,7.5,4.2,6938|9242|10365,TCF12|MSC|KLF2,-0.66,0
1,-2.8,C0349204,M1,1,0,DisGeNET,35,Nonorganic psychosis,,-2.8,8.1,5,30304,376,40,4,10,4.7,1745|2571|3479|5649,DLX1|GAD1|IGF1|RELN,-0.66,0
1,-2.8,C0035078,M1,1,0,DisGeNET,35,Kidney Failure,,-2.8,8,5,30304,378,40,4,10,4.7,2138|3479|30010|221395,EYA1|IGF1|NXPH1|ADGRF5,-0.65,0
1,-2.8,C1334274,M1,1,0,DisGeNET,35,Invasive Carcinoma,,-2.8,13,5.8,30304,173,40,3,7.5,4.2,2078|2146|3479,ERG|EZH2|IGF1,-0.65,0
1,-2.8,C0085207,M1,1,0,DisGeNET,35,Gestational Diabetes,,-2.8,5.8,4.5,30304,649,40,5,12,5.2,2146|2571|3479|6256|9242,EZH2|GAD1|IGF1|RXRA|MSC,-0.65,0
1,-2.8,C0023487,M1,1,0,DisGeNET,35,Acute Promyelocytic Leukemia,,-2.8,5.8,4.5,30304,651,40,5,12,5.2,2078|2122|2146|6256|9242,ERG|MECOM|EZH2|RXRA|MSC,-0.65,0
1,-2.8,C0038868,M1,1,0,DisGeNET,35,Progressive supranuclear palsy,,-2.8,13,5.8,30304,176,40,3,7.5,4.2,1745|3479|84959,DLX1|IGF1|UBASH3B,-0.64,0
1,-2.8,C0037369,M1,1,0,DisGeNET,35,Smoking,,-2.8,7.8,4.9,30304,391,40,4,10,4.7,6913|9760|65217|285987,TBX15|TOX|PCDH15|DLX6-AS1,-0.62,0
1,-2.8,C1535939,M1,1,0,DisGeNET,35,Pneumocystis jiroveci pneumonia,,-2.8,13,5.7,30304,180,40,3,7.5,4.2,2078|2571|84959,ERG|GAD1|UBASH3B,-0.62,0
1,-2.8,C0282160,M1,1,0,DisGeNET,35,Aplasia Cutis Congenita,,-2.8,7.7,4.9,30304,392,40,4,10,4.7,864|2146|3479|4603,RUNX3|EZH2|IGF1|MYBL1,-0.62,0
1,-2.8,C0026985,M1,1,0,DisGeNET,35,Myelodysplasia,,-2.8,13,5.7,30304,181,40,3,7.5,4.2,2122|2146|3479,MECOM|EZH2|IGF1,-0.62,0
1,-2.8,C0399526,M1,1,0,DisGeNET,35,Class III malocclusion,,-2.8,13,5.7,30304,181,40,3,7.5,4.2,2146|3479|84959,EZH2|IGF1|UBASH3B,-0.62,0
1,-2.7,C4721579,M1,1,0,DisGeNET,35,Secondary malignant neoplasm of colon and/or rectum,,-2.7,7.6,4.8,30304,397,40,4,10,4.7,2146|3479|22806|84959,EZH2|IGF1|IKZF3|UBASH3B,-0.6,0
1,-2.7,C0026277,M1,1,0,DisGeNET,35,Mixed Salivary Gland Tumor,,-2.7,12,5.6,30304,185,40,3,7.5,4.2,864|3479|4603,RUNX3|IGF1|MYBL1,-0.6,0
1,-2.7,C0221356,M1,1,0,DisGeNET,35,Brachycephaly,,-2.7,12,5.6,30304,186,40,3,7.5,4.2,2146|6938|63976,EZH2|TCF12|PRDM16,-0.59,0
1,-2.7,C0878500,M1,1,0,DisGeNET,35,Intraepithelial Neoplasia,,-2.7,12,5.6,30304,186,40,3,7.5,4.2,864|2146|3479,RUNX3|EZH2|IGF1,-0.59,0
1,-2.7,C0031099,M1,1,0,DisGeNET,35,Periodontitis,,-2.7,5.6,4.4,30304,680,40,5,12,5.2,639|2571|3479|6256|6938,PRDM1|GAD1|IGF1|RXRA|TCF12,-0.59,0
1,-2.7,C1654637,M1,1,0,DisGeNET,35,androgen independent prostate cancer,,-2.7,12,5.5,30304,190,40,3,7.5,4.2,2078|2146|63976,ERG|EZH2|PRDM16,-0.57,0
1,-2.7,C0024115,M1,1,0,DisGeNET,35,Lung diseases,,-2.7,5.4,4.3,30304,700,40,5,12,5.2,2146|3479|9242|10365|221395,EZH2|IGF1|MSC|KLF2|ADGRF5,-0.54,0
1,-2.7,C0740394,M1,1,0,DisGeNET,35,Hyperuricemia,,-2.7,12,5.4,30304,196,40,3,7.5,4.2,2146|8537|10365,EZH2|BCAS1|KLF2,-0.54,0
1,-2.6,C1836542,M1,1,0,DisGeNET,35,Depressed nasal bridge,,-2.6,7.1,4.6,30304,426,40,4,10,4.7,2138|2146|6660|63976,EYA1|EZH2|SOX5|PRDM16,-0.52,0
1,-2.6,C4552766,M1,1,0,DisGeNET,35,Miscarriage,,-2.6,7.1,4.6,30304,426,40,4,10,4.7,2146|3479|6256|23213,EZH2|IGF1|RXRA|SULF1,-0.52,0
1,-2.6,C0542476,M1,1,0,DisGeNET,35,Forgetful,,-2.6,7.1,4.6,30304,429,40,4,10,4.7,2146|2571|3479|5649,EZH2|GAD1|IGF1|RELN,-0.51,0
1,-2.6,C0042834,M1,1,0,DisGeNET,35,Vital capacity,,-2.6,7,4.6,30304,430,40,4,10,4.7,2122|3479|9586|55553,MECOM|IGF1|CREB5|SOX6,-0.51,0
1,-2.6,C0524910,M1,1,0,DisGeNET,35,"Hepatitis C, Chronic",,-2.6,7,4.6,30304,430,40,4,10,4.7,2078|2571|3479|5649,ERG|GAD1|IGF1|RELN,-0.51,0
1,-2.6,C0333983,M1,1,0,DisGeNET,35,Hyperplastic Polyp,,-2.6,11,5.3,30304,204,40,3,7.5,4.2,864|2146|3479,RUNX3|EZH2|IGF1,-0.5,0
1,-2.6,C0035222,M1,1,0,DisGeNET,35,"Respiratory Distress Syndrome, Adult",,-2.6,7,4.6,30304,434,40,4,10,4.7,2078|2571|3479|10365,ERG|GAD1|IGF1|KLF2,-0.5,0
1,-2.6,C1384666,M1,1,0,DisGeNET,35,hearing impairment,,-2.6,5.1,4.1,30304,739,40,5,12,5.2,2138|3479|6913|6938|65217,EYA1|IGF1|TBX15|TCF12|PCDH15,-0.46,0
1,-2.6,C1843013,M1,1,0,DisGeNET,35,"Alzheimer disease, familial, type 3",,-2.6,11,5.1,30304,213,40,3,7.5,4.2,2146|3479|6660,EZH2|IGF1|SOX5,-0.46,0
1,-2.5,C0011615,M1,1,0,DisGeNET,35,"Dermatitis, Atopic",,-2.5,5,4.1,30304,751,40,5,12,5.2,9242|9760|22806|51705|84959,MSC|TOX|IKZF3|EMCN|UBASH3B,-0.44,0
1,-2.5,C0006012,M1,1,0,DisGeNET,35,Borderline Personality Disorder,,-2.5,10,5,30304,221,40,3,7.5,4.2,2138|2571|5649,EYA1|GAD1|RELN,-0.42,0
1,-2.5,C0233794,M1,1,0,DisGeNET,35,Memory impairment,,-2.5,5,4,30304,763,40,5,12,5.2,2146|2571|3479|5649|9242,EZH2|GAD1|IGF1|RELN|MSC,-0.41,0
1,-2.5,C0200665,M1,1,0,DisGeNET,35,Platelet mean volume determination (procedure),,-2.5,10,5,30304,223,40,3,7.5,4.2,6938|63976|221395,TCF12|PRDM16|ADGRF5,-0.41,0
1,-2.5,C0030297,M1,1,0,DisGeNET,35,Pancreatic Neoplasm,,-2.5,5,4,30304,764,40,5,12,5.2,864|2146|3479|5649|23213,RUNX3|EZH2|IGF1|RELN|SULF1,-0.41,0
1,-2.5,C0013080,M1,1,0,DisGeNET,35,Down Syndrome,,-2.5,5,4,30304,765,40,5,12,5.2,2078|2146|2571|5649|63976,ERG|EZH2|GAD1|RELN|PRDM16,-0.41,0
1,-2.5,C0027796,M1,1,0,DisGeNET,35,Neuralgia,,-2.5,4.9,4,30304,766,40,5,12,5.2,864|2146|2571|6938|9242,RUNX3|EZH2|GAD1|TCF12|MSC,-0.41,0
1,-2.5,C0155626,M1,1,0,DisGeNET,35,Acute myocardial infarction,,-2.5,4.9,4,30304,766,40,5,12,5.2,864|3479|9242|10365|55553,RUNX3|IGF1|MSC|KLF2|SOX6,-0.41,0
1,-2.5,C4721414,M1,1,0,DisGeNET,35,Mantle cell lymphoma,,-2.5,6.5,4.4,30304,466,40,4,10,4.7,639|2146|3479|10365,PRDM1|EZH2|IGF1|KLF2,-0.41,0
1,-2.5,C0345905,M1,1,0,DisGeNET,35,Intrahepatic Cholangiocarcinoma,,-2.5,6.4,4.3,30304,470,40,4,10,4.7,864|2122|2146|3479,RUNX3|MECOM|EZH2|IGF1,-0.4,0
1,-2.5,C0020255,M1,1,0,DisGeNET,35,Hydrocephalus,,-2.5,6.4,4.3,30304,473,40,4,10,4.7,2138|3479|6913|63976,EYA1|IGF1|TBX15|PRDM16,-0.39,0
1,-2.5,C0040128,M1,1,0,DisGeNET,35,Thyroid Diseases,,-2.5,9.9,4.9,30304,230,40,3,7.5,4.2,2571|3479|22806,GAD1|IGF1|IKZF3,-0.39,0
1,-2.5,C0282612,M1,1,0,DisGeNET,35,Prostatic Intraepithelial Neoplasias,,-2.5,9.9,4.9,30304,230,40,3,7.5,4.2,2078|3479|6256,ERG|IGF1|RXRA,-0.39,0
1,-2.4,C3887461,M1,1,0,DisGeNET,35,Head and Neck Carcinoma,,-2.4,4.8,3.9,30304,786,40,5,12,5.2,864|2146|3479|6938|27333,RUNX3|EZH2|IGF1|TCF12|GOLIM4,-0.38,0
1,-2.4,C0376634,M1,1,0,DisGeNET,35,Craniofacial Abnormalities,,-2.4,9.7,4.9,30304,234,40,3,7.5,4.2,1745|2138|6913,DLX1|EYA1|TBX15,-0.38,0
1,-2.4,C3665346,M1,1,0,DisGeNET,35,Unspecified visual loss,,-2.4,9.7,4.9,30304,235,40,3,7.5,4.2,2078|2571|65217,ERG|GAD1|PCDH15,-0.37,0
1,-2.4,C0202117,M1,1,0,DisGeNET,35,Low density lipoprotein cholesterol measurement,,-2.4,6.3,4.2,30304,483,40,4,10,4.7,2122|6256|6938|55553,MECOM|RXRA|TCF12|SOX6,-0.37,0
1,-2.4,C2347748,M1,1,0,DisGeNET,35,Adult Erythroleukemia,,-2.4,9.6,4.8,30304,236,40,3,7.5,4.2,2078|2146|84959,ERG|EZH2|UBASH3B,-0.37,0
1,-2.4,C4520840,M1,1,0,DisGeNET,35,Erythroleukemia (Erythroid/Myeloid),,-2.4,9.6,4.8,30304,237,40,3,7.5,4.2,2078|2146|84959,ERG|EZH2|UBASH3B,-0.37,0
1,-2.4,C0007124,M1,1,0,DisGeNET,35,Noninfiltrating Intraductal Carcinoma,,-2.4,6.2,4.2,30304,486,40,4,10,4.7,864|2078|2146|23213,RUNX3|ERG|EZH2|SULF1,-0.37,0
1,-2.4,C1445957,M1,1,0,DisGeNET,35,Serum total cholesterol measurement,,-2.4,6.2,4.2,30304,486,40,4,10,4.7,2122|6256|6938|84959,MECOM|RXRA|TCF12|UBASH3B,-0.37,0
1,-2.4,C0010278,M1,1,0,DisGeNET,35,Craniosynostosis,,-2.4,6.2,4.2,30304,488,40,4,10,4.7,2146|3479|6938|55553,EZH2|IGF1|TCF12|SOX6,-0.37,0
1,-2.4,C2004493,M1,1,0,DisGeNET,35,"Leukemia, B-Cell",,-2.4,9.5,4.8,30304,239,40,3,7.5,4.2,2078|2122|2146,ERG|MECOM|EZH2,-0.37,0
1,-2.4,C3888194,M1,1,0,DisGeNET,35,MIXED LINEAGE LEUKEMIA,,-2.4,9.5,4.8,30304,240,40,3,7.5,4.2,2122|2146|3479,MECOM|EZH2|IGF1,-0.37,0
1,-2.4,C0002170,M1,1,0,DisGeNET,35,Alopecia,,-2.4,6.2,4.2,30304,491,40,4,10,4.7,864|3479|6913|6938,RUNX3|IGF1|TBX15|TCF12,-0.37,0
1,-2.4,C0007789,M1,1,0,DisGeNET,35,Cerebral Palsy,,-2.4,9.4,4.8,30304,241,40,3,7.5,4.2,2571|3479|9242,GAD1|IGF1|MSC,-0.37,0
1,-2.4,C0025362,M1,1,0,DisGeNET,35,Mental Retardation,,-2.4,6,4.1,30304,504,40,4,10,4.7,1745|3479|6938|30010,DLX1|IGF1|TCF12|NXPH1,-0.35,0
1,-2.4,C0280324,M1,1,0,DisGeNET,35,Laryngeal Squamous Cell Carcinoma,,-2.4,6,4.1,30304,504,40,4,10,4.7,864|2146|3479|285987,RUNX3|EZH2|IGF1|DLX6-AS1,-0.35,0
1,-2.4,C1332201,M1,1,0,DisGeNET,35,Adult Diffuse Large B-Cell Lymphoma,,-2.4,6,4.1,30304,504,40,4,10,4.7,639|864|2146|3479,PRDM1|RUNX3|EZH2|IGF1,-0.35,0
1,-2.4,C0489786,M1,1,0,DisGeNET,35,Height,,-2.4,9.1,4.7,30304,249,40,3,7.5,4.2,3479|23213|170691,IGF1|SULF1|ADAMTS17,-0.35,0
1,-2.3,C0020295,M1,1,0,DisGeNET,35,Hydronephrosis,,-2.3,9,4.6,30304,252,40,3,7.5,4.2,2138|6913|63976,EYA1|TBX15|PRDM16,-0.34,0
1,-2.3,C2938924,M1,1,0,DisGeNET,35,Oestrogen receptor positive breast cancer,,-2.3,5.9,4.1,30304,510,40,4,10,4.7,864|2146|3479|84959,RUNX3|EZH2|IGF1|UBASH3B,-0.34,0
1,-2.3,C0030312,M1,1,0,DisGeNET,35,Pancytopenia,,-2.3,9,4.6,30304,253,40,3,7.5,4.2,864|2078|2122,RUNX3|ERG|MECOM,-0.34,0
1,-2.3,C3489532,M1,1,0,DisGeNET,35,Cone-Rod Dystrophy 2,,-2.3,9,4.6,30304,253,40,3,7.5,4.2,2078|3479|9242,ERG|IGF1|MSC,-0.34,0
1,-2.3,C4703473,M1,1,0,DisGeNET,35,Atherosclerotic lesion,,-2.3,9,4.6,30304,253,40,3,7.5,4.2,3479|6256|10365,IGF1|RXRA|KLF2,-0.34,0
1,-2.3,C0018916,M1,1,0,DisGeNET,35,Hemangioma,,-2.3,8.9,4.6,30304,256,40,3,7.5,4.2,2078|3479|51705,ERG|IGF1|EMCN,-0.33,0
1,-2.3,C0281361,M1,1,0,DisGeNET,35,Adenocarcinoma of pancreas,,-2.3,5.9,4,30304,518,40,4,10,4.7,864|2146|3479|6256,RUNX3|EZH2|IGF1|RXRA,-0.33,0
1,-2.3,C0014170,M1,1,0,DisGeNET,35,Endometrial Neoplasms,,-2.3,8.7,4.5,30304,261,40,3,7.5,4.2,864|2146|3479,RUNX3|EZH2|IGF1,-0.32,0
1,-2.3,C2826323,M1,1,0,DisGeNET,35,Refractory Cytopenia of Childhood,,-2.3,8.6,4.5,30304,264,40,3,7.5,4.2,2146|3479|84959,EZH2|IGF1|UBASH3B,-0.31,0
1,-2.3,C0598935,M1,1,0,DisGeNET,35,Tumor Initiation,,-2.3,5.7,4,30304,533,40,4,10,4.7,864|2078|2146|3479,RUNX3|ERG|EZH2|IGF1,-0.31,0
1,-2.3,C0428474,M1,1,0,DisGeNET,35,Serum LDL cholesterol measurement,,-2.3,8.4,4.5,30304,269,40,3,7.5,4.2,2122|6256|55553,MECOM|RXRA|SOX6,-0.3,0
1,-2.3,C0524587,M1,1,0,DisGeNET,35,Mean Corpuscular Volume (result),,-2.3,8.4,4.5,30304,269,40,3,7.5,4.2,2078|55553|63976,ERG|SOX6|PRDM16,-0.3,0
1,-2.3,C0002793,M1,1,0,DisGeNET,35,Anaplasia,,-2.3,5.6,3.9,30304,538,40,4,10,4.7,2078|2146|3479|6660,ERG|EZH2|IGF1|SOX5,-0.3,0
1,-2.3,C0940937,M1,1,0,DisGeNET,35,precancerous lesions,,-2.3,8.4,4.5,30304,270,40,3,7.5,4.2,864|2146|23213,RUNX3|EZH2|SULF1,-0.3,0
1,-2.3,C0029925,M1,1,0,DisGeNET,35,Ovarian Carcinoma,,-2.3,5.6,3.9,30304,539,40,4,10,4.7,864|2122|2146|3479,RUNX3|MECOM|EZH2|IGF1,-0.3,0
1,-2.3,C0016529,M1,1,0,DisGeNET,35,Forced expiratory volume function,,-2.3,8.4,4.4,30304,272,40,3,7.5,4.2,2122|3479|65217,MECOM|IGF1|PCDH15,-0.3,0
1,-2.2,C4284013,M1,1,0,DisGeNET,35,Primary cholangiocarcinoma of intrahepatic biliary tract,,-2.2,8.3,4.4,30304,274,40,3,7.5,4.2,864|2122|2146,RUNX3|MECOM|EZH2,-0.3,0
1,-2.2,C0392885,M1,1,0,DisGeNET,35,High density lipoprotein measurement,,-2.2,5.6,3.9,30304,545,40,4,10,4.7,3479|6256|55553|84959,IGF1|RXRA|SOX6|UBASH3B,-0.3,0
1,-2.2,C0428472,M1,1,0,DisGeNET,35,Serum HDL cholesterol measurement,,-2.2,8,4.3,30304,283,40,3,7.5,4.2,3479|6256|55553,IGF1|RXRA|SOX6,-0.26,0
1,-2.2,C0033975,M1,1,0,DisGeNET,35,Psychotic Disorders,,-2.2,5.4,3.8,30304,560,40,4,10,4.7,1745|2571|3479|5649,DLX1|GAD1|IGF1|RELN,-0.26,0
1,-2.2,C0205682,M1,1,0,DisGeNET,35,Waist-Hip Ratio,,-2.2,5.4,3.8,30304,565,40,4,10,4.7,2122|2138|6913|63976,MECOM|EYA1|TBX15|PRDM16,-0.25,0
1,-2.2,C0042133,M1,1,0,DisGeNET,35,Uterine Fibroids,,-2.2,5.3,3.8,30304,569,40,4,10,4.7,2146|3479|6256|375612,EZH2|IGF1|RXRA|LHFPL3,-0.24,0
1,-2.2,C0032463,M1,1,0,DisGeNET,35,Polycythemia Vera,,-2.2,7.8,4.2,30304,291,40,3,7.5,4.2,2122|2146|3479,MECOM|EZH2|IGF1,-0.24,0
1,-2.2,C0040100,M1,1,0,DisGeNET,35,Thymoma,,-2.2,7.8,4.2,30304,291,40,3,7.5,4.2,864|2122|3479,RUNX3|MECOM|IGF1,-0.24,0
1,-2.2,C0153633,M1,1,0,DisGeNET,35,Malignant neoplasm of brain,,-2.2,7.7,4.2,30304,294,40,3,7.5,4.2,2146|6938|23213,EZH2|TCF12|SULF1,-0.23,0
1,-2.2,C0334634,M1,1,0,DisGeNET,35,"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse",,-2.2,7.7,4.2,30304,296,40,3,7.5,4.2,639|2146|3479,PRDM1|EZH2|IGF1,-0.22,0
1,-2.2,C0525045,M1,1,0,DisGeNET,35,Mood Disorders,,-2.2,5.2,3.7,30304,580,40,4,10,4.7,2571|5649|51705|55553,GAD1|RELN|EMCN|SOX6,-0.22,0
1,-2.1,C0005699,M1,1,0,DisGeNET,35,Blast Phase,,-2.1,7.6,4.2,30304,299,40,3,7.5,4.2,2078|2122|3479,ERG|MECOM|IGF1,-0.22,0
1,-2.1,C0039101,M1,1,0,DisGeNET,35,synovial sarcoma,,-2.1,7.6,4.2,30304,299,40,3,7.5,4.2,2078|2146|3479,ERG|EZH2|IGF1,-0.22,0
1,-2.1,C0206180,M1,1,0,DisGeNET,35,Ki-1+ Anaplastic Large Cell Lymphoma,,-2.1,7.6,4.2,30304,300,40,3,7.5,4.2,639|2146|3479,PRDM1|EZH2|IGF1,-0.21,0
1,-2.1,C0025990,M1,1,0,DisGeNET,35,Micrognathism,,-2.1,5.2,3.7,30304,586,40,4,10,4.7,2138|2146|3479|6913,EYA1|EZH2|IGF1|TBX15,-0.21,0
1,-2.1,C0027708,M1,1,0,DisGeNET,35,Nephroblastoma,,-2.1,5.2,3.7,30304,586,40,4,10,4.7,864|2138|2146|3479,RUNX3|EYA1|EZH2|IGF1,-0.21,0
1,-2.1,C0023440,M1,1,0,DisGeNET,35,Acute Erythroblastic Leukemia,,-2.1,7.5,4.1,30304,302,40,3,7.5,4.2,2078|2146|84959,ERG|EZH2|UBASH3B,-0.21,0
1,-2.1,C0427460,M1,1,0,DisGeNET,35,Red cell distribution width determination,,-2.1,5.1,3.7,30304,593,40,4,10,4.7,2122|2146|8537|55553,MECOM|EZH2|BCAS1|SOX6,-0.2,0
1,-2.1,C1304746,M1,1,0,DisGeNET,35,RDW - Red blood cell distribution width result,,-2.1,5.1,3.7,30304,593,40,4,10,4.7,2122|2146|8537|55553,MECOM|EZH2|BCAS1|SOX6,-0.2,0
1,-2.1,C0027404,M1,1,0,DisGeNET,35,Narcolepsy,,-2.1,7.4,4.1,30304,308,40,3,7.5,4.2,30010|57633|100130231,NXPH1|LRRN1|LINC00861,-0.19,0
1,-2.1,C0009241,M1,1,0,DisGeNET,35,Cognition Disorders,,-2.1,5,3.6,30304,606,40,4,10,4.7,2571|3479|5649|6256,GAD1|IGF1|RELN|RXRA,-0.17,0
1,-2.1,C0200638,M1,1,0,DisGeNET,35,Eosinophil count procedure,,-2.1,5,3.6,30304,610,40,4,10,4.7,864|2078|9586|22806,RUNX3|ERG|CREB5|IKZF3,-0.16,0
1,-2.1,C0004623,M1,1,0,DisGeNET,35,Bacterial Infections,,-2.1,4.9,3.6,30304,616,40,4,10,4.7,864|2146|3479|9242,RUNX3|EZH2|IGF1|MSC,-0.15,0
1,-2,C1368683,M1,1,0,DisGeNET,35,Epithelioma,,-2,7,3.9,30304,326,40,3,7.5,4.2,864|2146|3479,RUNX3|EZH2|IGF1,-0.13,0
1,-2,C0740391,M1,1,0,DisGeNET,35,Middle Cerebral Artery Occlusion,,-2,4.8,3.5,30304,626,40,4,10,4.7,2571|3479|9242|10365,GAD1|IGF1|MSC|KLF2,-0.13,0
1,-2,C0524528,M1,1,0,DisGeNET,35,Pervasive Development Disorder,,-2,6.9,3.9,30304,328,40,3,7.5,4.2,2146|5649|57194,EZH2|RELN|ATP10A,-0.13,0
1,-2,C4048329,M1,1,0,DisGeNET,35,Immunosuppression,,-2,4.8,3.5,30304,632,40,4,10,4.7,3479|9242|9586|23213,IGF1|MSC|CREB5|SULF1,-0.12,0
1,-2,C0677607,M1,1,0,DisGeNET,35,Hashimoto Disease,,-2,6.8,3.9,30304,335,40,3,7.5,4.2,2571|3479|22806,GAD1|IGF1|IKZF3,-0.1,0
1,-2,C0085669,M1,1,0,DisGeNET,35,Acute leukemia,,-2,4.7,3.5,30304,639,40,4,10,4.7,864|2078|2122|2146,RUNX3|ERG|MECOM|EZH2,-0.1,0
